Analytical Data
-
Gene name
EFNA5
- Application
-
Alternative Names
AF1; EFL5; EPLG7; GLC1M; LERK7; RAGS; AL-1; EPH-related receptor tyrosine kinase ligand 7
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P52803
-
Expression Region
Gln21~Asn203
-
Molecular Weight
27kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EFNA5 (Ephrin-A5) is a critical member of the ephrin family, which plays a significant role in various biological processes, including cell adhesion, migration, and neuron guidance. Research on EFNA5 has gained considerable attention due to its involvement in developmental processes and its potential implications in various diseases, including cancer and neurological disorders. The EFNA5 protein is known to interact with Eph receptors, mediating bidirectional signaling that influences cellular behaviors. This makes EFNA5 an important target for understanding tumor microenvironments and neuronal circuitry. The generation of recombinant EFNA5 can facilitate in-depth studies of its structure-function relationships and elucidate its role in pathophysiological contexts. Investigating EFNA5's interactions and signaling pathways using reconstituted systems can help uncover its contributions to oncogenesis and neurodevelopment, paving the way for novel therapeutic strategies. Additionally, the production of this recombinant protein allows for the exploration of its potential as a biomarker in clinical settings, further enhancing our understanding of its significance in health and disease.
